R Pg Family Wealth Advisory, LLC Vaxart, Inc. Transaction History

R Pg Family Wealth Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.6 - $1.41 $15,000 - $35,250	25,000 New	25,000 $18,000
Q3 2020 Nov 10, 2020	BUY	$4.78 - $16.97 $47,800 - $169,700	10,000 New	10,000 $66,000
Q2 2020 Aug 10, 2020	SELL	$1.68 - $8.85 $16,800 - $88,500	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.95 - $9.02 $49,500 - $90,200	10,000 New	10,000 $0

108

37.9M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.